2

Preventing postnatal depression: A causal mediation analysis of a 20-year preconception cohort

Postnatal depression (PND) is common and predicts a range of adverse maternal and offspring outcomes. PND rates are highest among women with persistent mental health problems before pregnancy, and antenatal healthcare provides ideal opportunity to …

Examining longitudinal associations between self-reported depression, anxiety and stress symptoms and hair cortisol among mothers of young children

**Background:** Maternal mental health is critically important given its impacts on both women's and children's outcomes. Hair cortisol concentrations (HCC) may provide insight into physiological processes underpinning mental health. This study …

A comparison of two measures to screen for mental health symptoms in pregnancy and early postpartum: the Matthey Generic Mood Questionnaire and the Depression, Anxiety, Stress Scales short-form

**Background:** The Matthey Generic Mood Questionnaire (MGMQ) provides a rapid screen of clinically significant emotional difficulties in adults. This study aimed to investigate associations between the MGMQ and Depression Anxiety Stress Scales …

Parental mental health before and during pregnancy and offspring birth outcomes: A 20-year preconception cohort of maternal and paternal exposure

**Background:** Preterm birth (PTB) and small for gestational age (SGA) are increasingly prevalent, with major consequences for health and development into later life. There is emerging evidence that some risk processes begin before pregnancy. We …

Validation of the OWLS, a screening tool for measuring prescription opioid use disorder in primary care

**Objective:** The OWLS is a screening tool for prescription opioid use disorder designed for use in primary care. This study aimed to confirm the optimal wording, scoring methods, and cutoff for the OWLS. **Design and Setting:** Cross-sectional …

Validity and reliability of the computer-administered routine opioid outcome monitoring (ROOM) tool

**Objective:** The Routine Opioid Outcome Monitoring (ROOM) tool measures outcomes with opioids using an established framework which includes domains such as pain, mood, opioid use disorder, alcohol use, and constipation. This study aims to validate …

Comparing rates and charateristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Victoria, Australia from 2013 to 2018

**Background and aims:** Despite increases in opioid prescribing and related morbidity and mortality, few studies have comprehensively documented harms across opioid types. We examined a population‐wide indicator of extramedical pharmaceutical …

Changes in Australian prescription opioid use following codeine rescheduling: A retrospective study using pharmaceutical benefits data

**Purpose:** In February 2018, Australia up-scheduled the 'weak' opioid codeine to a prescription only medication. This study aimed to analyse the change in prescribing trends for codeine and other commonly prescribed opioids in Australia following …

Recent trends in heroin and pharmaceutical opioid-related harms in Victroia, Australia up to 2018

**Aims:** To characterize the trajectory in the years leading up to 2018 in pharmaceutical opioid and heroin morbidity in Victoria, Australia, and to assess the effect on that trajectory of reformulation of oxycodone to a form that could not be …

Comparing rates and charateristics of ambulance attendances relted to extramedical us of pharmaceuticalopioids in Australia: a protocol for a retrospective observational study

**Introduction and aims:** Extramedical use of, and associated harms with pharmaceutical opioids are common. Analysis of coded ambulance clinical records provides a unique opportunity to examine a national population-level indicator of relative …